ProCE Banner Activity

Advancing CRS Care: EDS-FLU and the Future of Treatment Options

Clinical Thought

Read my commentary on the classification of chronic rhinosinusitis (CRS) with or without nasal polyps, first-line treatment options, and role of exhalational delivery systems with fluticasone (EDS-FLU) as an FDA-approved option to improve symptom management.

Released: December 09, 2024

Expiration: December 08, 2025

Share

Faculty

Edward El Rassi

Edward El Rassi, MD

Assistant Professor
Rhinology and Skull Base Surgery
Department of Otolaryngology, Head and Neck Surgery
University of Oklahoma College of Medicine
University of Oklahoma Health
Oklahoma City, Oklahoma

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Optinose US, Inc.

Optinose US, Inc.

Disclosure

Primary Author

Edward El Rassi, MD

Assistant Professor
Rhinology and Skull Base Surgery
Department of Otolaryngology, Head and Neck Surgery
University of Oklahoma College of Medicine
University of Oklahoma Health
Oklahoma City, Oklahoma

Edward El Rassi, MD, has no relevant financial relationships to disclose.